COMPANY
MatTek
NIH awards 50
- NIH award 1R43ES032363-01 FY2020: $252,129 awarded for that fiscal year; activity R43 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Organotypic Culture Models (OCM) developed fro source ↗
- NIH award 1R43ES031044-01 FY2019: $223,936 awarded for that fiscal year; activity R43 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Organotypic Rat Tissue Models for Translationa source ↗
- NIH award 1R43ES030648-01 FY2019: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Novel Approach for Characterizing Exposure and source ↗
- NIH award 5U44ES014312-06 FY2019: $241,361 awarded for that fiscal year; activity U44 (SBIR); PI KALUZHNY, YULIA; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Validation of an In Vitro Human Airway Model fo source ↗
- NIH award 5U44ES014312-05 FY2018: $530,965 awarded for that fiscal year; activity U44 (SBIR); PI HAYDEN, PATRICK J; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Validation of an In Vitro Human Airway Model source ↗
- NIH award 5R44GM108164-04 FY2018: $172,979 awarded for that fiscal year; activity R44 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. An In Vitro Human Small Intestine Tissue Model source ↗
- NIH award 2U44ES014312-04 FY2017: $431,027 awarded for that fiscal year; activity U44 (SBIR); PI HAYDEN, PATRICK J; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Validation of an In Vitro Human Airway Model source ↗
- NIH award 5R44GM108164-03 FY2017: $507,987 awarded for that fiscal year; activity R44 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. An In Vitro Human Small Intestine Tissue Model source ↗
- NIH award 2R44GM108164-02 FY2016: $648,815 awarded for that fiscal year; activity R44 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. An In Vitro Human Small Intestine Tissue Model source ↗
- NIH award 1R43GM108164-01A1 FY2014: $218,331 awarded for that fiscal year; activity R43 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. An In Vitro Human Small Intestine Tissue Mod source ↗
- NIH award 5R21AI104385-02 FY2014: $221,953 awarded for that fiscal year; activity R21 (OTHER_NIH); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Use of a CB2 Ligand to prevent HIV-1 Inf source ↗
- NIH award 1R21AI104385-01A1 FY2013: $218,399 awarded for that fiscal year; activity R21 (OTHER_NIH); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Use of a CB2 Ligand to prevent HIV-1 I source ↗
- NIH award 5R44GM084551-03 FY2013: $483,227 awarded for that fiscal year; activity R44 (SBIR); PI HAYDEN, PATRICK J; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Genetically modified tissue engineered in vit source ↗
- NIH award 5R44ES020074-04 FY2013: $181,578 awarded for that fiscal year; activity R44 (SBIR); PI KALUZHNY, YULIA; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Human Corneal Model for Ocular Irritation Assay source ↗
- NIH award 5R44ES015641-04 FY2013: $189,035 awarded for that fiscal year; activity R44 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Validation of Human Vaginal Tissue Assay for E source ↗
- NIH award 2R44GM084551-02 FY2012: $483,227 awarded for that fiscal year; activity R44 (SBIR); PI HAYDEN, PATRICK J; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Genetically modified tissue engineered in vit source ↗
- NIH award 5R44ES015641-03 FY2012: $460,766 awarded for that fiscal year; activity R44 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Validation of Human Vaginal Tissue Assay for E source ↗
- NIH award 5R44ES014312-03 FY2012: $537,491 awarded for that fiscal year; activity R44 (SBIR); PI HAYDEN, PATRICK J; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Validation of an In Vitro Human Airway Model source ↗
- NIH award 5R44ES020074-03 FY2012: $390,762 awarded for that fiscal year; activity R44 (SBIR); PI KALUZHNY, YULIA; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Human Corneal Model for Ocular Irritation Assay source ↗
- NIH award 5R44HD050023-04 FY2011: $197,217 awarded for that fiscal year; activity R44 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Validation of a Human In Vitro Vaginal Irritat source ↗
- NIH award 2R44ES014312-02 FY2011: $298,491 awarded for that fiscal year; activity R44 (SBIR); PI HAYDEN, PATRICK J; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Validation of an In Vitro Human Airway Model source ↗
- NIH award 9R44ES020074-02 FY2011: $352,177 awarded for that fiscal year; activity R44 (SBIR); PI KALUZHNY, YULIA; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Human Corneal Model for Ocular Irritation Assay source ↗
- NIH award 2R44ES015641-02 FY2011: $327,839 awarded for that fiscal year; activity R44 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Validation of Human Vaginal Tissue Assay for E source ↗
- NIH award 1R43GM093563-01 FY2010: $267,914 awarded for that fiscal year; activity R43 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. In Vitro Human Tissue Model for Intravaginal D source ↗
- NIH award 5R44HD050023-03 FY2010: $491,867 awarded for that fiscal year; activity R44 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Validation of a Human In Vitro Vaginal Irritat source ↗
- NIH award 5U01AI070914-05 FY2010: $619,724 awarded for that fiscal year; activity U01 (OTHER_NIH); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Vaginal/cervical tissue models: endocrine source ↗
- NIH award 5R44AR052982-03 FY2010: $436,471 awarded for that fiscal year; activity R44 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. In Vitro Tissue Model of Psoriasis source ↗
- NIH award 5R44ES015002-03 FY2010: $433,658 awarded for that fiscal year; activity R44 (SBIR); PI KALUZHNY, YULIA; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Reconstructed Skin Micronucleus Genotoxicity As source ↗
- NIH award 2R44ES015002-02A1 FY2009: $385,446 awarded for that fiscal year; activity R44 (SBIR); PI KALUZHNY, YULIA; recipient as written: MATTEK CORPORATION, ASHLAND, MA. Reconstructed Skin Micronucleus Genotoxicity source ↗
- NIH award 2R44AR052982-02 FY2009: $434,712 awarded for that fiscal year; activity R44 (SBIR); PI AYEHUNIE, SEYOUM; recipient as written: MATTEK CORPORATION, ASHLAND, MA. In Vitro Tissue Model of Psoriasis source ↗